Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.

Fisher J, Sharma R, Don DW, Barisa M, Hurtado MO, Abramowski P, Porter L, Day W, Borea R, Inglott S, Anderson J, Pe'er D.

Sci Signal. 2019 Sep 10;12(598). pii: eaax1872. doi: 10.1126/scisignal.aax1872.

PMID:
31506382
2.

Activated Stromal Cells Transfer Mitochondria to Rescue Acute Lymphoblastic Leukaemia Cells from Oxidative Stress.

Burt R, Dey A, Aref S, Aguiar M, Akarca A, Bailey K, Day W, Hooper S, Kirkwood A, Kirschner K, Lee S, Lo Celso C, Manji J, Mansour MR, Marafioti T, Mitchell RJ, Muirhead RC, Ng KCY, Pospori C, Puccio I, Zuborne-Alapi K, Sahai E, Fielding AK.

Blood. 2019 Sep 9. pii: blood.2019001398. doi: 10.1182/blood.2019001398. [Epub ahead of print]

PMID:
31501154
3.

Severe scurvy in an adult male without clear risk factors for nutritional deficiency.

Day W, Gyurjyan-Bunch A, Van Voorhees A.

JAAD Case Rep. 2019 Apr 1;5(4):309-311. doi: 10.1016/j.jdcr.2019.01.031. eCollection 2019 Apr. No abstract available.

4.

Borderline lepromatous leprosy masking as tinea versicolor.

Day W, Prodanovic E.

Int J Dermatol. 2019 Jun;58(6):e125-e126. doi: 10.1111/ijd.14439. Epub 2019 Mar 19. No abstract available.

PMID:
30891732
5.

Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts.

Zbesko JC, Nguyen TV, Yang T, Frye JB, Hussain O, Hayes M, Chung A, Day WA, Stepanovic K, Krumberger M, Mona J, Longo FM, Doyle KP.

Neurobiol Dis. 2018 Apr;112:63-78. doi: 10.1016/j.nbd.2018.01.007. Epub 2018 Jan 10.

6.
7.

Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies.

Zhang W, Hubbard A, Jones T, Racolta A, Bhaumik S, Cummins N, Zhang L, Garsha K, Ventura F, Lefever MR, Lu Z, Hurley JK, Day WA, Pestic-Dragovich L, Morrison LE, Tang L.

Lab Invest. 2017 Jul;97(7):873-885. doi: 10.1038/labinvest.2017.37. Epub 2017 May 15.

8.

Enriching gene expression profiles will help personalize prostate cancer management for African-Americans: A perspective.

Vijayakumar S, Henegan JC, Zhang X, Wang W, Day WA, Vijayakumar V, Moreno CS, Gomez CR.

Urol Oncol. 2017 Jun;35(6):315-321. doi: 10.1016/j.urolonc.2017.04.003. Epub 2017 May 2. Review.

PMID:
28476530
9.

Covalently deposited dyes: a new chromogen paradigm that facilitates analysis of multiple biomarkers in situ.

Day WA, Lefever MR, Ochs RL, Pedata A, Behman LJ, Ashworth-Sharpe J, Johnson DD, May EJ, Grille JG, Roberts EA, Kosmeder JW, Morrison LE.

Lab Invest. 2017 Jan;97(1):104-113. doi: 10.1038/labinvest.2016.115. Epub 2016 Nov 21.

10.

The Analysis of Cell Cycle, Proliferation, and Asymmetric Cell Division by Imaging Flow Cytometry.

Filby A, Day W, Purewal S, Martinez-Martin N.

Methods Mol Biol. 2016;1389:71-95. doi: 10.1007/978-1-4939-3302-0_5.

PMID:
27460238
11.

Elevated Expression of Hepatoma Up-Regulated Protein Inhibits γ-Irradiation-Induced Apoptosis of Prostate Cancer Cells.

Hassan M, El Khattouti A, Ejaeidi A, Ma T, Day WA, Espinoza I, Vijayakumar S, Gomez CR.

J Cell Biochem. 2016 Jun;117(6):1308-18. doi: 10.1002/jcb.25419. Epub 2015 Nov 17.

PMID:
26505164
12.

Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model.

McClanahan F, Riches JC, Miller S, Day WP, Kotsiou E, Neuberg D, Croce CM, Capasso M, Gribben JG.

Blood. 2015 Jul 9;126(2):212-21. doi: 10.1182/blood-2015-02-626754. Epub 2015 May 15.

13.

Appraising the suitability of succinimidyl and lipophilic fluorescent dyes to track proliferation in non-quiescent cells by dye dilution.

Filby A, Begum J, Jalal M, Day W.

Methods. 2015 Jul 1;82:29-37. doi: 10.1016/j.ymeth.2015.02.016. Epub 2015 Mar 20.

PMID:
25802116
14.

Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study.

Hellstrom WJ, Kaminetsky J, Belkoff LH, Goldstein I, Tursi JP, Uy J, Peterson CA, Bowden CH, Day WW.

J Urol. 2015 Aug;194(2):485-92. doi: 10.1016/j.juro.2014.12.101. Epub 2015 Jan 12.

PMID:
25591992
15.

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.

Rimsza LM, Day WA, McGinn S, Pedata A, Natkunam Y, Warnke R, Cook JR, Marafioti T, Grogan TM.

Diagn Pathol. 2014 Jul 21;9:144. doi: 10.1186/1746-1596-9-144.

16.

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.

Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N.

J Hypertens. 2014 Jun;32(6):1178-88. doi: 10.1097/HJH.0000000000000145. Review.

17.

A method for evaluating the use of fluorescent dyes to track proliferation in cell lines by dye dilution.

Begum J, Day W, Henderson C, Purewal S, Cerveira J, Summers H, Rees P, Davies D, Filby A.

Cytometry A. 2013 Dec;83(12):1085-95. doi: 10.1002/cyto.a.22403. Epub 2013 Oct 25.

18.

Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.

Garvey WT, Ryan DH, Henry R, Bohannon NJ, Toplak H, Schwiers M, Troupin B, Day WW.

Diabetes Care. 2014 Apr;37(4):912-21. doi: 10.2337/dc13-1518. Epub 2013 Oct 8.

19.

An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction.

Belkoff LH, McCullough A, Goldstein I, Jones L, Bowden CH, DiDonato K, Trask B, Day WW.

Int J Clin Pract. 2013 Apr;67(4):333-41. doi: 10.1111/ijcp.12065.

PMID:
23521325
20.

Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2).

Davidson MH, Tonstad S, Oparil S, Schwiers M, Day WW, Bowden CH.

Am J Cardiol. 2013 Apr 15;111(8):1131-8. doi: 10.1016/j.amjcard.2012.12.038. Epub 2013 Jan 29.

21.

Single incision laparoscopic right hemicolectomy: different approaches.

Wong TM, Day W, Kwok SY, Lau YY, Yip WC.

Chin Med J (Engl). 2013 Jan;126(2):238-41.

PMID:
23324270
22.

A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy.

Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, DiDonato K, Shih W, Day WW.

J Urol. 2013 Jun;189(6):2229-36. doi: 10.1016/j.juro.2012.11.177. Epub 2012 Dec 3.

PMID:
23219537
23.

Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus.

Goldstein I, Jones LA, Belkoff LH, Karlin GS, Bowden CH, Peterson CA, Trask BA, Day WW.

Mayo Clin Proc. 2012 Sep;87(9):843-52. doi: 10.1016/j.mayocp.2012.06.016. Epub 2012 Aug 1.

24.

Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.

Wang R, Burnett AL, Heller WH, Omori K, Kotera J, Kikkawa K, Yee S, Day WW, DiDonato K, Peterson CA.

J Sex Med. 2012 Aug;9(8):2122-9. doi: 10.1111/j.1743-6109.2012.02822.x. Epub 2012 Jul 3.

PMID:
22759639
25.

Investigations of Salmonella enterica serovar newport infections of oysters by using immunohistochemistry and knockout mutagenesis.

Morrison CM, Dial SM, Day WA Jr, Joens LA.

Appl Environ Microbiol. 2012 Apr;78(8):2867-73. doi: 10.1128/AEM.07456-11. Epub 2012 Feb 3.

26.

A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction.

Goldstein I, McCullough AR, Jones LA, Hellstrom WJ, Bowden CH, Didonato K, Trask B, Day WW.

J Sex Med. 2012 Apr;9(4):1122-33. doi: 10.1111/j.1743-6109.2011.02629.x. Epub 2012 Jan 16.

PMID:
22248153
27.

Food and Chemical Toxicology, 2010, Association of phenylbutazone usage in horses bought for slaughter: a public health risk.

Henneke D, King S, Day WE, Evans P.

Food Chem Toxicol. 2012 Mar;50(3-4):603; author reply 455-6. doi: 10.1016/j.fct.2012.01.010. Epub 2012 Jan 12. No abstract available.

PMID:
22245664
28.

Primary colorectal lymphoma: case series and literature review.

She WH, Day W, Lau PY, Mak KL, Yip AW.

Asian J Surg. 2011 Jul;34(3):111-4. doi: 10.1016/j.asjsur.2011.08.004. Epub 2011 Oct 22. Review.

29.

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.

Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH.

Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7.

30.

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).

Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW.

Obesity (Silver Spring). 2012 Feb;20(2):330-42. doi: 10.1038/oby.2011.330. Epub 2011 Nov 3.

31.

Deficiencies in acetyl-CoA carboxylase and fatty acid synthase 1 differentially affect eggshell formation and blood meal digestion in Aedes aegypti.

Alabaster A, Isoe J, Zhou G, Lee A, Murphy A, Day WA, Miesfeld RL.

Insect Biochem Mol Biol. 2011 Dec;41(12):946-55. doi: 10.1016/j.ibmb.2011.09.004. Epub 2011 Sep 29.

32.

Novel "glove" access port for single port surgery in right hemicolectomy: a pilot study.

Day W, Lau P.

Surg Laparosc Endosc Percutan Tech. 2011 Jun;21(3):e145-7. doi: 10.1097/SLE.0b013e31821aa97e.

PMID:
21654290
33.

Defects in coatomer protein I (COPI) transport cause blood feeding-induced mortality in Yellow Fever mosquitoes.

Isoe J, Collins J, Badgandi H, Day WA, Miesfeld RL.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):E211-7. doi: 10.1073/pnas.1102637108. Epub 2011 May 31.

34.

Alpha-COPI coatomer protein is required for rough endoplasmic reticulum whorl formation in mosquito midgut epithelial cells.

Zhou G, Isoe J, Day WA, Miesfeld RL.

PLoS One. 2011 Mar 31;6(3):e18150. doi: 10.1371/journal.pone.0018150.

35.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.

Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW.

Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8. Erratum in: Lancet. 2011 Apr 30;377(9776):1494.

PMID:
21481449
36.
37.

A small bowel lymphangioma presenting as a volvulus.

Day W, Kan DM.

Hong Kong Med J. 2010 Jun;16(3):233-4. No abstract available.

38.

Use of laparoscopic deployable vascular clamp for bowel control in on-table colonoscopy during laparoscopic colectomy.

Day W, Lau PY, Yip AW.

Surg Laparosc Endosc Percutan Tech. 2010 Apr;20(2):e54-6. doi: 10.1097/SLE.0b013e3181cf0afd.

PMID:
20393320
39.

Capsule depolymerase overexpression reduces Bacillus anthracis virulence.

Scorpio A, Chabot DJ, Day WA, Hoover TA, Friedlander AM.

Microbiology. 2010 May;156(Pt 5):1459-67. doi: 10.1099/mic.0.035857-0. Epub 2010 Jan 28.

PMID:
20110296
40.

Impact of the standardized medial-to-lateral approach on outcome of laparoscopic colorectal resection. is it a fair comparison?

Day W, Lau PY.

World J Surg. 2010 May;34(5):1146-7; author reply 1148-9. doi: 10.1007/s00268-009-0383-x. No abstract available.

41.

Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.

Morton TL, Gattermeir DJ, Petersen CA, Day WW, Schumacher RJ.

J Clin Pharmacol. 2009 Sep;49(9):1037-46. doi: 10.1177/0091270009339187. Epub 2009 Jul 23.

PMID:
19628730
42.

Steps in predicting the relationship of yield on fungicide dose.

Paveley ND, Sylvester-Bradley R, Scott RK, Craigon J, Day W.

Phytopathology. 2001 Jul;91(7):708-16. doi: 10.1094/PHYTO.2001.91.7.708.

43.

The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.

Schumacher RJ, Gattermeir DJ, Peterson CA, Wisdom C, Day WW.

Menopause. 2009 Jan-Feb;16(1):177-83. doi: 10.1097/gme.0b013e31817e2c77.

PMID:
18779758
44.

Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.

Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.

Obstet Gynecol. 2008 Jun;111(6):1343-51. doi: 10.1097/AOG.0b013e318175d162.

PMID:
18515518
45.

Explosions and hot spots in supertree methods.

Day WH, McMorris FR, Wilkinson M.

J Theor Biol. 2008 Jul 21;253(2):345-8. doi: 10.1016/j.jtbi.2008.03.024. Epub 2008 Mar 27.

PMID:
18472112
47.

An engineering approach to modelling, decision support and control for sustainable systems.

Day W, Audsley E, Frost AR.

Philos Trans R Soc Lond B Biol Sci. 2008 Feb 12;363(1491):527-41. Review.

48.
49.

Salicylate and catechol levels are maintained in nahG transgenic poplar.

Morse AM, Tschaplinski TJ, Dervinis C, Pijut PM, Schmelz EA, Day W, Davis JM.

Phytochemistry. 2007 Aug;68(15):2043-52. Epub 2007 Jun 27.

PMID:
17599371
50.

Optimisation of the separation of herbicides by linear gradient high performance liquid chromatography utilising artificial neural networks.

Tran AT, Hyne RV, Pablo F, Day WR, Doble P.

Talanta. 2007 Feb 28;71(3):1268-75. doi: 10.1016/j.talanta.2006.06.031. Epub 2006 Aug 14.

PMID:
19071444

Supplemental Content

Support Center